Jabagat, Vicselyn A.
HRN: 26-50-65 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2025
CEFUROXIME 1.5GM (VIAL)
03/19/2025
03/20/2025
IV
1.5g
Q8hrs
S/P LSTCS
Waiting Final Action
03/19/2025
CEFUROXIME 500MG (TAB)
03/19/2025
03/26/2025
ORAL
500mg
BID
S/P LSTCS
Waiting Final Action